INFORMATION TO AUTHORS

PLEASE FOLLOW THE INSTRUCTIONS

Home / AUTHORS

Instructions to Authors       PDF

  • Iraqi National Journal of Medicine (IqNJM) is Double-blind, peer-reviewed, open access, a biannual publication with a single volume, and two issues. The journal is published by the Iraqi Association for Medical Research and Studies (IAMRS).

The aim of IqNJM is to support the research community and promote conducting high standard scientific research in Iraq and the region, facilitating the development of medical research, education and health services and providing an opportunity to authors to their work widely spread and increase the visibility of it by open access policy,  in order to make Iraqi and regional scientific work available to the widest possible global audience so Researchers all over the world can evaluate it and use that data to have a more global scientific view. IqNJM tries to achieve its goal by the following measures:

 

1. Authors support and Author friendly policy.

  • Free of charge submission, reviewing, biostatistical evaluation, plagiarism scanning, proofreading, publication, and printing
  • Author friendly submission policy making it easy for the Author whether to communicate with us with email, WhatsApp, or others.
  • Peer review, acceptance, and publication time ranging from 3-6months

 

2. implementing the Research and Publication Ethic’s by creating an Ethical committee in the Iraqi Association for Medical research and studies (IAMRS) & IqNJM that is reviewing the Author’s Documents and papers Provided from institutional Ethical committees and manuscripts for errors in this fields and ensuring that the paper is the fulfilment of the highest word  Research Ethic’s standards  According to Helsinki declaration, ARRIVE (Animals in Research: Reporting In Vivo Experiments) statement, rules of the National Institution of Health (NIH) in the care and use of animal in medical research, and the Core practice Guidelines of COPE for publication Ethics.

 

3. The journal is working hard to be indexed in the widest indexing sits in the word. After it has been indexed in the official Iraqi indexing site the Iraqi Academic Scientific journals IASJ and international indexing in EBSCO it is also Archived and receiving DOI from Crossref, ROAD the journal is working to be included in DOAJ, PubMed, and Scopus.

IqNJM is working to have the Open Journal System to facilitate the transparency of its work.

The IqNJM covers all fields in medicine with a special interest in publications with clinical relevance. Basic sciences/ experimental studies are also welcomed, the journal is accepting a wide range of scientific work like original articles (including randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, cost-effectiveness analyses, case-control series and surveys with high response rate), review of literature and meta-analysis, Cohort studies, Clinical trials, case series and case reports, ideas and innovations, letters to the editor, Discussions. IqNJM is targeting national, regional, international researches and directed to worldwide Audience.

 This is an open-access journal, published as an online and paper version is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The journal follows the international standards of publication according to the Committee on Publication Ethics (COPE), Office of Research Integrity (ORI), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME).

The journal is adopting An Author friendly policy to facilitate manuscript submission, Author’s can use Email (preferable) or WhatsApp or other social media to communicate with the journal office.

To submit your work use the journal office Email contact@iqnjm.com

Or WhatsApp on the NO. 009647801336393 or 009647721669983

The Papers required are

 

1- The covering letter should include the corresponding author and all the contributing authors with their scientific degrees, places of work, and contact information. All authors need to sign the acceptance of the right of publication by the IqNJM. To download the Covering letter click here.

 

2-The title page should include the title of the article with the name of all authors, their affiliations, and contact information, in addition to a running title.

 

3- Abstract page including a structured abstract including background, objectives, methods, results, conclusions, and Keywords

 

 

Structure of the Manuscript

  1. Introduction and aim of the study
  2. Materials and Methods
  3. Results
  4. Discussion
  5. Conclusions
  6. Acknowledgments
  7. Conflict of interest
  8. Authors contribution
  • The text should be in American English format, 12 point Times New Roman font, and double spaced.
  • The style of the main titles like Introduction, material and methods, Results, Discussion, Conclusions, Recommendations, and References; should be written in all caps format, 12 point Times New Roman font, Bold and turquoise basic color.
  • The subtitles should be in the 12 point Times New Roman font, bold, black.
  • The main table heading should be in 10 point Times New Roman font BOLD
  • Tables should be in 8 point Times New Roman font, single-spaced
  • Headings within tables should be in 8 points BOLD
  • When referred to in the text should have the following format Ex. (Table 6)
  • The main figure heading should be in 10 point Times New Roman font BOLD
  • Legends should be in 10 points, single-spaced
  • Figures should be in separate papers and JPEG format with the highest resolution possible.
  • Figures should not have legend embedded in it, the legend should be typed in word format below each figure.
  • When referred to in the text should have the following format Ex. (Fig. 6)

The Journal use Vancouver Style of referencing as shown the Examples below

 

Article example

Hafezi F, Nouhi A. Safe abdominoplasty with extensive liposuctioning. Annals of plastic surgery. 2006 Aug 1; 57(2):149-53.

 

Book example

Smith J, Aston S. Grabb and Smith’s plastic surgery. Plastic Surgical Nursing. 1991 Apr 1; 11(1):29.

 

Case report example

Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nature medicine. 2003 Apr 1; 9(4):448-52.

 

 

 

Review of literature example

Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. The Journal of clinical psychiatry. 2001

 

 

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to IqNJM alone at that point in time and has not been published anywhere or simultaneously submitted/accepted for publication elsewhere. All submitted manuscripts are checked for plagiarism. Manuscripts are then sent to a minimum of two independent expert reviewers for assessing the scientific quality of the manuscript. The Journal follows a double-blind review process. The comments and suggestions (i.e., acceptance or rejection of or revisions in manuscript) received from reviewers are conveyed to the corresponding author. If a manuscript is requested to be revised, the author(s) is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. Manuscripts accepted for publication are copyedited for language, grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within one week.

Manuscripts submitted to journals are privileged communications that are authors’ private, confidential property, Reviewers therefore should keep manuscripts and the information they contain strictly confidential. Reviewers must not publicly discuss authors’ work and must not appropriate authors’ ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews.

Reviewers are expected to respond promptly to requests to review and to submit reviews within the time agreed. Reviewers’ comments should be constructive, honest, and polite. Reviewers should declare their relationships and activities that might bias their evaluation of a manuscript and recuse themselves from the peer-review process if a conflict exists.

Authorship credit should be based only on substantial contributions to each of the four components mentioned below:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged.  Examples of suitable acknowledgments may include people who assisted with technical analysis, manuscript preparation, study design, or data collection. Other entities may include funders, in-kind contributors, clinician investigators, or interviewers. Additional guidance on authorship and acknowledgments is provided by the International Committee of Medical Journal Editors (ICMJE).

All authors must disclose all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

If IqNJM receives a manuscript for publication consideration from its Editorial Board members, IqNJM ensures that the entire editorial process is carried out in an unbiased manner and that members who may have a conflict of interest with the manuscript do not take part in any editorial decision of the manuscript. The peer review of such a manuscript is completed by reviewers with no conflict of interest.

 IqNJM requires all articles reporting results of clinical trials to be registered in a public trials registry that is in conformity with the International Committee of Medical Journal Editors (ICMJE). All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. Phase I trials designed to study pharmacokinetics or major toxicity are exempt.

Manuscripts reporting on clinical trials (as defined above) should indicate that the trial is registered and include the registry information on a separate page, immediately following the author’s financial disclosure information. Required registry information includes the trial registry name, registration identification number, and the URL for the registry.

 Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent/guardian, wherever applicable) provides informed consent for publication. The authors should remove patients’ names from figures unless they have obtained informed consent from the patients. The journal abides by the ICMJE guidelines:

  • Authors, and not the Journal or its Publisher, need to obtain the patient consent form before submitting their work for publication consideration to IqNJM. The authors should ensure that this patient consent form(s) is properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to the Editorial or Publisher offices.
  • If the manuscript contains patient images that preclude anonymity or a description that has an obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.

 For duplicate publication, fabricated data, undisclosed conflict of interest, plagiarism and/or other issues of publication and scientific misconduct, IqNJM follows the guidance produced by Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE). Misconduct can be raised against authors, reviewers, editors, and others.

IqNJM endeavor’s to avoid all possible misconduct. All manuscripts are checked for plagiarism using Plag Scan. If the Editor or a reviewer is concerned that some aspect of a submitted article may constitute misconduct in research, publication, or professional behavior, the Journal communicates the same to the author(s) and seeks clarification. However, if the concerns are not satisfactorily resolved by discussion with the author(s), the Journal may report the same to appropriate authorities such as their institutions and, for duplicate publication, the journal in which the previous publication had appeared.

The Journal also encourages its readers to report any published article in which they suspect misconduct through e-mail or letter. The anonymity of the complainant would always be maintained.

 In respect to the Iraqi Copyright Protection Law No. (3) of 1971, we are declaring our copyrights policy

For Authors

As soon as an article is accepted for publication, authors will hold the copyright and publishing rights without restrictions. Also, the Authors should notice that the journal is publishing their contents on the web as an open-access journal according to the creative commons attribution – non-commercial 4.0 International (CCBY-NC) license, and making numbers of printed copies for the Authors personal non-commercial use

http://creativecommons.org/licenses/by-nc/4.0/

More information about the Iraqi copyright law can be found in the link below http://iraqld.hjc.iq:8080/LoadLawBook.aspx?SC=031220056443402

For Readers

While the advice and information in this journal are believed to be true and accurate at the date of publication, neither the authors, the editor nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty with respect to the material contained herein. The entire contents of the Iraqi National Journal of Medicine are protected under Iraqi and international copyrights. However, the Journal grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy use distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights.

This procedure applies to complaints about the publishing policies, procedures, and/or actions of the Iraqi National Journal of Medicine editorial staff. This complaint must relate to content or a procedure that was the responsibility of the IqNJM or its Editor.

 

How to register a complaint

Complaints can be registered by phone, e-mail, or letter to the address provided in the Contacts section. The Journal prefers communication through e-mail because it provides a reliable trail. All complaints are acknowledged at the earliest. The complaint would be followed-up in an unbiased manner and be handled by the person to whom they are made, if possible. The Journal aims to resolve any complaint raised within 2–4 weeks; however, if that is not possible, an interim response would be provided until the complaint is resolved.

 

External body

If a complainant remains unsatisfied with the final decision of the Editor, the complainant may complain to an external body such as Committee on Publication Ethics, when that body has relevant oversight.

 Corrections are needed for errors of fact. Matters of the debate are best handled as letters to the editor, like print or electronic correspondence. Updates of previous publications (e.g., an updated systematic review or clinical guideline) are considered a new publication rather than a version of a previously published article.

 

If a correction is needed,  the journal is following these standards: The journal will publish a correction notice as soon as possible detailing changes from and citing the original publication; the correction should be on an electronic or numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing.

  • The journal also will post a new article version with details of the changes from the original version and the date(s) on which the changes were made.
  • The journal will archive all prior versions of the article. This archive can be either directly accessible to readers or can be made available to the reader on request.
  • Previous electronic versions will prominently note that there are more recent versions of the article.
  • The citation will be the most recent version.

Journals should include policies on data availability and encourage the use of reporting guidelines and registration of clinical trials and other study designs according to standard practice in their discipline.

Duplicate Submission

Authors should not submit the same manuscript, in the same or different languages, simultaneously to more than one journal. The rationale for this standard is the potential for disagreement when two (or more) journals claim the right to publish a manuscript that has been submitted simultaneously to more than one journal, and the possibility that two or more journals will unknowingly and unnecessarily undertake the work of peer review, edit the same manuscript, and publish the same article.

 

Duplicate and Prior Publication

Duplicate publication is a publication of a paper that overlaps substantially with one already published, without clear, visible reference to the previous publication. Prior publication may include the release of information in the public domain. In the event of a public health emergency (as defined by public health officials), information with immediate implications for public health should be disseminated without concern that this will preclude subsequent consideration for publication in a journal. We encourage editors to give priority to authors who have made crucial data publicly available (e.g., in a gene bank) without delay. The ICMJE will not consider as prior publication the posting of trial results in any registry that meets the criteria noted in Section III.L. If results are limited to a brief (500 words) structured abstract or tables (to include participants enrolled, key outcomes, and adverse events). The ICMJE encourages authors to include a statement with the registration that indicates that the results have not yet been published in a peer-reviewed journal, and to update the results registry with the full journal citation when the results are published.

Authors who attempt duplicate publication without such notification should expect at least prompt rejection of the submitted manuscript. If the editor was not aware of the violations and the article has already been published, then the article might warrant retraction with or without the author’s explanation or approval.

 

Acceptable Secondary Publication

Secondary publication of material published in other journals or online may be justifiable and beneficial, especially when intended to disseminate important information to the widest possible audience (e.g., guidelines produced by government agencies and professional organizations in the same or a different language). Secondary publication for various other reasons may also be justifiable provided the following conditions are met:

  1. 1. The authors have received approval from the editors of both journals (the editor concerned with secondary publication must have access to the primary version).
  2. 2. The priority of the primary publication is respected by a publication interval negotiated by both editors with the authors.
  3. 3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
  4. 4. The secondary version faithfully reflects the authors, data, and interpretations of the primary version.
  5. 5. The secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part elsewhere—for example, with a note that might read, “This article is based on a study first reported in the [journal title, with full reference]”—and the secondary version cites the primary reference.
  6. The title of the secondary publication should indicate that it is a secondary publication (complete or abridged republication or translation) of a primary publication. Of note, the NLM does not consider translations to be “republications” and does not cite or index them when the original article was published in a journal that is indexed in MEDLINE.

the IqNJM is depending in its funding from the owner of the journal IAMRS and donations. It depends on in its work on voluntary workers with no salary paid to any one of its staff.

the IqNJM in its print version is distributed to the Authors and Universities in Iraq and Scientific Institutions that have a collaboration with IAMRS and to Iraqi Scientist free of charge.

IqNJM Adopted an Authors support and Author friendly policy. Free of charge submission, reviewing, biostatistical evaluation, plagiarism scanning, proofreading, publication, and printing

To start submission please Download  the Covering letter

to Download the COVERING LETTER Click here

then print the PDF file and fill it and all Authors should sign the document

scan the final document and send it back by Email contact@iqnjm.com

Submission:

The journal is adopting An Author friendly policy to facilitate manuscript submission, Author’s can use Email (preferable) or WhatsApp or other social media to communicate with the journal office.

To submit your work use the journal office Email contact@iqnjm.com

Or WhatsApp on the NO. 009647801336393 or 009647721669983

 

Submission requirement

Language of submission should be English (United States of America)

 

1- The covering letter should include the corresponding author and all the contributing authors with their scientific degrees, places of work, and contact information. All authors need to sign the acceptance of the right of publication by the IqNJM. To download the Covering letter click here.

 

2-The title page should include the title of the article with the name of all authors, their affiliations, and contact information, in addition to a running title.

 

3- Abstract page including a structured abstract including background, objectives, methods, results, conclusions, and Keywords

 

 

Structure of the Manuscript

  1. Introduction and aim of the study
  2. Materials and Methods
  3. Results
  4. Discussion
  5. Conclusions
  6. Acknowledgments
  7. Conflict of interest
  8. Authors contribution

 

Text format

  • The text should be in American English format, 12 point Times New Roman font, and double spaced.
  • The style of the main titles like Introduction, material and methods, Results, Discussion, Conclusions, Recommendations, and References; should be written in all caps format, 12 point Times New Roman font, Bold and turquoise basic color.
  • The subtitles should be in the 12 point Times New Roman font, bold, black.

Tables

  • The main table heading should be in 10 point Times New Roman font BOLD
  • Tables should be in 8 point Times New Roman font, single-spaced
  • Headings within tables should be in 8 points BOLD
  • When referred to in the text should have the following format Ex. (Table 6)

Figures

  • The main figure heading should be in 10 point Times New Roman font BOLD
  • Legends should be in 10 points, single-spaced
  • Figures should be in separate papers and JPEG format with the highest resolution possible.
  • Figures should not have legend embedded in it, the legend should be typed in word format below each figure.
  • When referred to in the text should have the following format Ex. (Fig. 6)

 

References

The Journal uses Vancouver Style of referencing as shown the Examples below

 

Article example

Hafezi F, Nouhi A. Safe abdominoplasty with extensive liposuctioning. Annals of plastic surgery. 2006 Aug 1; 57(2):149-53.

 

Book example

Smith J, Aston S. Grabb and Smith’s plastic surgery. Plastic Surgical Nursing. 1991 Apr 1; 11(1):29.

 

Case report example

Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nature medicine. 2003 Apr 1; 9(4):448-52.

 

 

 

 

Review of literature example

Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. The Journal of clinical psychiatry. 2001

to change the reference style to Vancouver Style in fast way  please download the

following PDF and follow instruction in it.